C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2011
11/03/2011	US20110269186 Antibodies against vascular endothelial growth factor receptor-1
11/03/2011	US20110269184 Method for controlling plasmid copy number in e.coli
11/03/2011	US20110269183 Recombinant microorganism having an ability of using sucrose as a carbon source
11/03/2011	US20110269146 Expression Vectors and Cell Lines Expressing Vascular Endothelial Growth Factor D, and Method of Treating Melanomas
11/03/2011	US20110269144 Ryanodine receptor polypeptides
11/03/2011	US20110269141 Target protein and target gene for drug discovery, and screening method
11/03/2011	US20110269133 Compositions and Methods For Detecting The Presence Of Cryptosporidium Parvum In A Test Sample
11/03/2011	US20110269122 Hereditary hemochromatosis gene
11/03/2011	US20110269120 Methods and compositions for detecting promoter activity and expressing fusionproteins
11/03/2011	US20110269119 Encoding text into nucleic acid sequences
11/03/2011	US20110269116 Cell Line From Rousettus As Host Cell For Pathogen Amplification
11/03/2011	US20110268810 Polymeric materials loaded with mutagenic and recombinagenic nucleic acids
11/03/2011	US20110268790 Snake Factor V and Methods of Use Thereof as a Procoagulant
11/03/2011	US20110268766 Engineered Cells Expressing Multiple Immunomodulators And Uses Thereof
11/03/2011	US20110268750 Chimeric polynucleotides and polypeptides enabling secretion of a polypeptide of interest in association with exosomes and use thereof for the production of immunogenic compositions
11/03/2011	US20110268747 Stxbp1 as psychiatric biomarker in murine model system and their uses
11/03/2011	US20110268746 Human cytomegalovirus neutralizing antibodies and use thereof
11/03/2011	US20110268739 Human binding molecules having killing activity against enterococci and uses thereof
11/03/2011	US20110268737 Hla-g proteins and pharmaceutical uses thereof
11/03/2011	US20110268735 Multimeric constructs
11/03/2011	US20110268727 Anti-interferon-alpha antibodies
11/03/2011	US20110268726 Anti-CD38 human antibodies and uses thereof
11/03/2011	US20110268724 Methods and materials relating to cd84-like polypeptides and polynucleotides
11/03/2011	US20110268713 Variants of Ancestral Uricases and Uses Thereof
11/03/2011	US20110268712 Stem Cells Suitable for Transplantation, Their Preparation and Pharmaceutical Compositions Comprising Them
11/03/2011	US20110268711 Pancreatic stellate cell specific promoter and uses thereof
11/03/2011	US20110268709 Generation of Histocompatible Tissues Using Nuclear Transplantation
11/03/2011	US20110268705 Hdac4, hdac5, hdac6, hdac7, and hif1 alpha modulation of retinal cell survival
11/03/2011	US20110268701 Stress-responsive induction of a therapeutic agent and methods of use
11/03/2011	US20110268673 Skin Treatment
11/03/2011	US20110268670 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
11/03/2011	US20110268661 Fluorescent fusion polypeptides and methods of use
11/03/2011	DE102010019059A1 Sensoren zur intrazellulären Metabolit-Detektion Sensors for intracellular metabolite detection
11/03/2011	CA2800818A1 Cationic lipid
11/03/2011	CA2800565A1 Anti-icam-1 single domain antibody and uses thereof
11/03/2011	CA2797865A1 Methods, compositions, and kits for the treatment of matrix mineralization disorders
11/03/2011	CA2797749A1 Enzymes
11/03/2011	CA2795799A1 Anti-erbb3 antibodies
11/02/2011	EP2383348A1 Method for adjusting amplification efficiency of target polynucleotide
11/02/2011	EP2383346A1 Method of increasing the function of an AAV vector
11/02/2011	EP2383345A1 Polynucleotides and polypeptides involved in plant fiber development and methods of using same
11/02/2011	EP2383344A1 Genes regulating plant branching, promoters, genetic constructs containing same and uses thereof
11/02/2011	EP2383343A2 Recombinant varicella-zoster virus
11/02/2011	EP2383342A1 Fusion proteins of mycobacterium tuberculosis antigens and their uses
11/02/2011	EP2383341A1 Compositions and methods for siRNA inhibition of angiogenesis
11/02/2011	EP2383340A2 Orthogonal translation components for the in vivo incorporation of unnatural amino acids
11/02/2011	EP2383339A1 Gene trapping for use in gene therapy
11/02/2011	EP2383338A1 Process for production of human type III collagen
11/02/2011	EP2383337A1 Novel promoter for use in transformation of algae
11/02/2011	EP2383336A1 Peptide capable of binding to immunoglobulin
11/02/2011	EP2383335A1 Process for producing nucleic acid sample, and process for producing nucleic acid amplification product using the nucleic acid sample
11/02/2011	EP2383334A1 Feeder cell for target cell induction
11/02/2011	EP2383297A1 Optimized antibodies that target CD19
11/02/2011	EP2383296A1 Antibody for the thyrotropin receptor and uses thereof
11/02/2011	EP2383291A2 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
11/02/2011	EP2383290A2 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
11/02/2011	EP2383287A1 Citrobacter rodentium secreted proteins
11/02/2011	EP2383282A1 Peptides for treatment of the human papillomavirus (HPV)-associated cancer and other epithelial tumors
11/02/2011	EP2383280A1 Expression system for toxic ion channels, in particular ryanodine receptors
11/02/2011	EP2382997A1 Compositions and methods for inhibiting expression of anti-apoptotic genes
11/02/2011	EP2382992A1 Pharmaceutical composition for treating obesity or diabetes
11/02/2011	EP2382982A2 Neural regeneration peptide and methods for their use in treatment of brain damage
11/02/2011	EP2382470A1 Measuring g protein coupled receptor activation
11/02/2011	EP2382323A2 Preparation and amplification of nucleic acids by means of magnetic particles
11/02/2011	EP2382319A1 A method for increasing protein expression in cells
11/02/2011	EP2382318A2 Novel bacillus thuringiensis gene with lepidopteran activity
11/02/2011	EP2382317A1 Tor-interacting proteins (tips) and genes therefor
11/02/2011	EP2382316A1 A recombinant alpha-hemolysin polypeptide of staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted
11/02/2011	EP2382315A1 Nucleic acid purification method
11/02/2011	EP2382314A1 C1orf59 peptides and vaccines including the same
11/02/2011	EP2382308A2 Enone reductases
11/02/2011	EP2382236A1 Fusion proteins forming trimers
11/02/2011	EP2382228A1 Compositions and methods of treating inflammatory and autoimmune diseases
11/02/2011	EP2381965A2 Modulation of pre-mrna using splice modulating oligonucleotides as therapeutic agents in the treatment of disease
11/02/2011	EP2381934A2 Improving cognitive function
11/02/2011	EP2381920A2 Methods and compositions for treating p.acnes
11/02/2011	EP2381788A2 Targeted cryptosporidium biocides
11/02/2011	EP2381782A1 Treatment of transgenic crops with mixtures of fiproles and chloronicotinyls
11/02/2011	EP2381781A1 Method for improved use of the production potential of genetically modified plants
11/02/2011	EP2381761A1 Genetically engineered herbicide resistant algae
11/02/2011	EP2222849B1 Method for the identification of targets for cancer therapy
11/02/2011	EP2147110B1 Novel simian t-cell lymphotropic virus
11/02/2011	EP2098594B1 NUCLEIC ACID MOLECULE CAPABLE OF BINDING TO RABBIT-DERIVED IgG ANTIBODY
11/02/2011	EP1869182B1 Method for isolation of soluble polypeptides
11/02/2011	EP1863334B1 Methods to generate drought-resistant plants
11/02/2011	EP1850130B1 Gene markers and utilzation of the same
11/02/2011	EP1836225B1 Kir-binding agents and methods of use thereof
11/02/2011	EP1659855B1 Rice plants having increased tolerance to imidazolinone herbicides
11/02/2011	EP1615952B1 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2
11/02/2011	EP1600509B1 Transgenic plant having fructooligosaccharide accumulated therein and process for constructing the same
11/02/2011	EP1589807B1 Transgenic pineapple plants with modified carotenoid levels and methods of their production
11/02/2011	EP1510581B1 Novel glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthase and gene encoding it
11/02/2011	EP1504092B1 Methods and compositions for using zinc finger endonucleases to enhance homologous recombination
11/02/2011	EP1425389B1 Human antibodies specific for interleukin 15 (il-15)
11/02/2011	EP1346030B1 Low-lipoxygenase 1 barley
11/02/2011	EP1311290B1 Expression of herstatin, an alternative her-2/neu product, in cells that express either p185her-2 or the egf receptor inhibits receptor activity and cell growth
11/02/2011	EP1299522B1 Alteration of cell membrane
11/02/2011	EP1230344B1 Plant biochemistry-related genes
11/02/2011	EP1212359B1 Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein
11/02/2011	EP1071710B2 Genomic sequence of the 5-lipoxygenase-activating protein (flap), polymorphic markers thereof and methods for detection of asthma

1 ... 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 ... 4023